Page last updated: 2024-12-10

3-deoxyhexulose

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

3-deoxyhexulose: interacts with the enzymes of fructose metabolism; structure given in first source; RN given refers to (D)-isomer; RN for cpd without isomeric designation not avail 5/91 [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

3-deoxy-keto-D-fructose : A deoxyketohexose that is keto-D-fructose that is lacking the hydroxy group at position 3. A metabolite of 3-deoxyglucosone, a dicarbonyl sugar synthesised through the Maillard reaction. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID3080627
CHEBI ID142685
SCHEMBL ID1168135
MeSH IDM0186824

Synonyms (11)

Synonym
3-deoxyfructose
d-erythro-2-hexulose, 3-deoxy-
3-deoxy-keto-d-fructose
3-deoxy-d-erythro-hex-2-ulose
CHEBI:142685
3-deoxyhexulose
(4s,5r)-1,4,5,6-tetrahydroxyhexan-2-one
3-deoxy-d-erythro-2-hexulose
6196-57-2
SCHEMBL1168135
DTXSID80210988
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (4)

ClassDescription
hexanoneA ketone that is a hexane carrying an oxo substituent at unspecified position.
alpha-hydroxy ketoneAn alpha-oxyketone that has a hydroxy group as the alpha-oxy moiety.
deoxyketohexoseAny ketohexose having at least one hydroxy group replaced by hydrogen.
beta-hydroxy ketoneA ketone containing a hydroxy group on the beta-carbon relative to the C=O group.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (11)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's5 (45.45)18.2507
2000's3 (27.27)29.6817
2010's3 (27.27)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.04

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.04 (24.57)
Research Supply Index2.48 (2.92)
Research Growth Index4.52 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.04)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies1 (9.09%)4.05%
Observational0 (0.00%)0.25%
Other10 (90.91%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]